Completed NA INTERVENTIONAL 1-arm NCT05416034

Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy

Study of the Impact of a Gait Exoskeleton on the Quality of Life of Patients With Spinal Muscular Atrophy

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Conditions Spinal Muscular Atrophy Type II

Interventions Use of the ATLAS 2025 exoskeleton at home

Updated 3 times since 2022 Last updated: Jun 10, 2022 Started: Dec 1, 2017 Primary completion: Jul 30, 2018 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05416034, this NA trial focuses on Spinal Muscular Atrophy Type II and remains completed. Sponsored by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal, it has been updated 3 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2022 — Jul 2024 [monthly]

Completed NA

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
MarsiBionics

Data source: MarsiBionics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain